1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))

C113H74N16O4Pt4 — CID 159131559

IUPAC1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))
SMILESCc1c2ccccc2nn1-c1[c-]c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)ccc1.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4cc5ccccc5n4)ccc3)ccc2)c2ccccc12.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4nc5ccccc5c4-c4ccccc4)ccc3)ccc2)c2ccccc12.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)cccc1-n1cc2ccccc2n1
InChIInChI=1S/C33H22N4O.2C27H18N4O.C26H16N4O.4Pt/c1-23-29-17-6-8-20-32(29)36(34-23)25-13-9-15-27(21-25)38-28-16-10-14-26(22-28)37-33(24-11-3-2-4-12-24)30-18-5-7-19-31(30)35-37;1-19-25-13-3-4-14-26(25)29-30(19)21-9-6-11-23(16-21)32-24-12-7-10-22(17-24)31-27-15-5-2-8-20(27)18-28-31;1-19-25-13-3-5-15-27(25)31(28-19)22-10-7-12-24(17-22)32-23-11-6-9-21(16-23)30-18-20-8-2-4-14-26(20)29-30;1-3-13-25-20(8-1)18-29(28-25)21-9-5-11-23(15-21)31-24-12-6-10-22(16-24)30-26-14-4-2-7-19(26)17-27-30;;;;/h2-20H,1H3;2*2-15,18H,1H3;1-14,17-18H;;;;/q4*-2;4*+2
InChIKeyJWSXETOXBARVRT-UHFFFAOYSA-N
MW2500.25 g/mol
LogP25.61
Rot. Bonds17

About 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))

1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) (PubChem CID 159131559) has the molecular formula C113H74N16O4Pt4 and a molecular weight of 2500.25 g/mol. Its IUPAC name is 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)).

Molecular Properties

Compound Name1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))
PubChem CID159131559
Molecular FormulaC113H74N16O4Pt4
Molecular Weight2500.25 g/mol
Exact Mass2498.47
IUPAC Name1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))
SMILESCc1c2ccccc2nn1-c1[c-]c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)ccc1.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4cc5ccccc5n4)ccc3)ccc2)c2ccccc12.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4nc5ccccc5c4-c4ccccc4)ccc3)ccc2)c2ccccc12.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)cccc1-n1cc2ccccc2n1
InChIInChI=1S/C33H22N4O.2C27H18N4O.C26H16N4O.4Pt/c1-23-29-17-6-8-20-32(29)36(34-23)25-13-9-15-27(21-25)38-28-16-10-14-26(22-28)37-33(24-11-3-2-4-12-24)30-18-5-7-19-31(30)35-37;1-19-25-13-3-4-14-26(25)29-30(19)21-9-6-11-23(16-21)32-24-12-7-10-22(17-24)31-27-15-5-2-8-20(27)18-28-31;1-19-25-13-3-5-15-27(25)31(28-19)22-10-7-12-24(17-22)32-23-11-6-9-21(16-23)30-18-20-8-2-4-14-26(20)29-30;1-3-13-25-20(8-1)18-29(28-25)21-9-5-11-23(15-21)31-24-12-6-10-22(16-24)30-26-14-4-2-7-19(26)17-27-30;;;;/h2-20H,1H3;2*2-15,18H,1H3;1-14,17-18H;;;;/q4*-2;4*+2
InChIKeyJWSXETOXBARVRT-UHFFFAOYSA-N
XLogP25.61
TPSA179.48 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds17
Heavy Atoms137
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002500.25
LogP ≤ 525.61
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))?
The IUPAC name of 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) (CID 159131559) is 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)).
What is the SMILES notation for 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))?
The canonical SMILES for 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) is Cc1c2ccccc2nn1-c1[c-]c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)ccc1.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4cc5ccccc5n4)ccc3)ccc2)c2ccccc12.Cc1nn(-c2[c-]c(Oc3[c-]c(-n4nc5ccccc5c4-c4ccccc4)ccc3)ccc2)c2ccccc12.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2[c-]c(-n3ncc4ccccc43)ccc2)cccc1-n1cc2ccccc2n1.
What is the InChIKey of 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))?
The InChIKey is JWSXETOXBARVRT-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H22N4O.2C27H18N4O.C26H16N4O.4Pt/c1-23-29-17-6-8-20-32(29)36(34-23)25-13-9-15-27(21-25)38-28-16-10-14-26(22-28)37-33(24-11-3-2-4-12-24)30-18-5-7-19-31(30)35-37;1-19-25-13-3-4-14-26(25)29-30(19)21-9-6-11-23(16-21)32-24-12-7-10-22(17-24)31-27-15-5-2-8-20(27)18-28-31;1-19-25-13-3-5-15-27(25)31(28-19)22-10-7-12-24(17-22)32-23-11-6-9-21(16-23)30-18-20-8-2-4-14-26(20)29-30;1-3-13-25-20(8-1)18-29(28-25)21-9-5-11-23(15-21)31-24-12-6-10-22(16-24)30-26-14-4-2-7-19(26)17-27-30;;;;/h2-20H,1H3;2*2-15,18H,1H3;1-14,17-18H;;;;/q4*-2;4*+2.
What are the key properties of 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+))?
1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) has a molecular weight of 2500.25 g/mol, XLogP of 25.61, 17 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]indazole;1-[3-(3-indazol-2-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-(3-indazol-1-ylbenzene-2-id-1-yl)oxybenzene-2-id-1-yl]-3-methylindazole;2-[3-[3-(3-methylindazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-3-phenylindazole;tetrakis(platinum(2+)) is sourced from PubChem (CID 159131559), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).